Doctor profile · Federal record
Dr. Caitlyn Erickson, PA
Medical Physician Assistant (CMS: Physician Assistant) · Hillsboro, OR
- NPI 1043793581
- Accepts Medicare
- 8 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
545 Se Oak St Ste F
Hillsboro, OR 971234147
(971) 228-8855
fax (503) 206-0118 - Additional location
-
1134 Sw Jefferson St Apt 308
Portland, OR 972013399
(541) 404-4993
Credentials & registration
- NPI registered
- September 2018 — 8 yrs on file
- Profile last updated
- October 29, 2020
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 363AM0700X — NUCC code
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1043793581. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
20,600
Distinct HCPCS
10
Medicare allowed
$317,124
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 18,750 | 29 | $13 | |
J0897 |
Injection, denosumab, 1 mg | 1,140 | 16 | $23 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 282 | 62 | $57 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 112 | 80 | $111 | |
96372 |
Injection of drug or substance under skin or into muscle | 59 | 27 | $12 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 51 | 14 | $25 | |
96375 |
Injection of additional new drug or substance into vein | 37 | 12 | $14 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 36 | 14 | $118 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 35 | 25 | $144 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 23 | 23 | $190 |
In context: peer comparison
Among 2 peers in Hillsboro Medical Physician Assistant, average services per provider: 1,290. This provider delivers 16× the peer median.Open Payments
Industry payments received
All-time total
$1,052
Transactions
53
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 8 | $241.14 | |
| Amgen INC. | 14 | $194.69 | |
| Abbvie INC. | 14 | $188.51 | |
| Janssen Biotech, INC. | 7 | $182.40 | |
| GlaxoSmithKline, LLC. | 2 | $52.85 | |
| Ucb, INC. | 2 | $44.08 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $27.37 | |
| Fresenius Kabi USA, LLC | 1 | $26.89 | |
| Ani Pharmaceuticals, INC. | 1 | $25.72 | |
| Celgene Corporation | 1 | $24.00 | |
| Novartis Pharmaceuticals Corporation | 1 | $23.37 | |
| Pfizer INC. | 1 | $21.36 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
935
Patients
289
Total drug cost
$131,771
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 213 | 81 | $10,623 |
| Prednisone | Generic | 159 | 65 | $1,748 |
| Hydroxychloroquine Sulfate | Generic | 145 | 52 | $8,975 |
| Allopurinol | Generic | 107 | 29 | $1,906 |
| Folic Acid | Generic | 52 | 20 | $292 |
| Methotrexate Sodium (Methotrexate Sodium/Pf) | Brand | 44 | 17 | $715 |
| Meloxicam | Generic | 36 | 12 | $88 |
| Leucovorin Calcium | Generic | 35 | 0 | $328 |
| Leflunomide | Generic | 30 | 0 | $2,362 |
| Celecoxib | Generic | 25 | 13 | $1,379 |
Hospital affiliations
Frequently asked questions
What is Dr. Caitlyn Erickson's medical specialty?
Dr. Caitlyn Erickson practices Medical Physician Assistant in Hillsboro, OR.
Where does Dr. Caitlyn Erickson practice?
Dr. Caitlyn Erickson practices at 545 Se Oak St Ste F, Hillsboro, OR 971234147. Office phone: 9712288855.
What is Dr. Caitlyn Erickson's NPI?
Dr. Caitlyn Erickson's National Provider Identifier (NPI) is 1043793581, issued by NPPES.
Does Dr. Caitlyn Erickson accept Medicare assignment?
Yes. Dr. Caitlyn Erickson accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Caitlyn Erickson commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, denosumab, 1 mg (HCPCS J0897); Infusion into a vein for therapy, prevention, or diagnosis (HCPCS 96365). Source: CMS Medicare Physician & Other Practitioners file.